124 related articles for article (PubMed ID: 36730554)
1. High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer.
Li Z; He S; Liu J; Zhi X; Yang L; Zhang J; Zhao R; Zhang R; Li L; Wang W
Anticancer Drugs; 2023 Apr; 34(4):479-482. PubMed ID: 36730554
[TBL] [Abstract][Full Text] [Related]
2. Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China.
Li K; Li L; Wu X; Yu J; Ma H; Zhang R; Li Y; Wang W
Dis Markers; 2019; 2019():3768708. PubMed ID: 31182980
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
Kim SY; Choi EJ; Yun JA; Jung ES; Oh ST; Kim JG; Kang WK; Lee SH
Int J Med Sci; 2015; 12(2):92-9. PubMed ID: 25589885
[TBL] [Abstract][Full Text] [Related]
4. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
[TBL] [Abstract][Full Text] [Related]
5. Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors.
Hashimoto Y; Skacel M; Adams JC
BMC Cancer; 2008 Jun; 8():185. PubMed ID: 18590537
[TBL] [Abstract][Full Text] [Related]
6. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.
Maeda T; Alexander CM; Friedl A
Cancer Res; 2004 Jan; 64(2):612-21. PubMed ID: 14744776
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
Miše I; Vučić M
Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.
Yang N; Mosher R; Seo S; Beebe D; Friedl A
Am J Pathol; 2011 Jan; 178(1):325-35. PubMed ID: 21224069
[TBL] [Abstract][Full Text] [Related]
9. A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
Sharpe B; Alghezi DA; Cattermole C; Beresford M; Bowen R; Mitchard J; Chalmers AD
Prostate; 2017 May; 77(13):1312-1324. PubMed ID: 28744948
[TBL] [Abstract][Full Text] [Related]
10. A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Kind S; Jaretzke A; Büscheck F; Möller K; Dum D; Höflmayer D; Hinsch A; Weidemann S; Fraune C; Möller-Koop C; Hube-Magg C; Simon R; Wilczak W; Lebok P; Witzel I; Müller V; Schmalfeldt B; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Krech T; Krech RH; von der Assen A; Bawahab AA; Burandt E
Mol Carcinog; 2019 Dec; 58(12):2306-2315. PubMed ID: 31545001
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
12. Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
Tanaka H; Hayashi H; Tomita H; Tokumaru Y; Fukada M; Tajima JY; Yokoi R; Tsuchiya H; Kuno M; Sato Y; Yasufuku I; Asai R; Mori R; Tanaka Y; Okumura N; Futamura M; Matsuhashi N
Anticancer Res; 2024 Apr; 44(4):1611-1618. PubMed ID: 38537984
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast.
Choi EJ; Yun JA; Jeon EK; Won HS; Ko YH; Kim SY
World J Surg Oncol; 2013 Dec; 11():314. PubMed ID: 24373193
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
16. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
Gharbaran R
Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.
Akl MR; Nagpal P; Ayoub NM; Prabhu SA; Gliksman M; Tai B; Hatipoglu A; Goy A; Suh KS
Oncotarget; 2015 Oct; 6(30):28693-715. PubMed ID: 26293675
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.
Lee SH; Choi EJ; Kim MS; Park JW; Lee YS; Kim SY; Kang CS
Int J Clin Oncol; 2014 Apr; 19(2):247-53. PubMed ID: 23553620
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.
Iida M; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Tokumitsu Y; Tomochika S; Tokuhisa Y; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Fujita K; Kuroda M; Nagano H
Oncol Rep; 2018 Sep; 40(3):1621-1631. PubMed ID: 30015977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]